Preview Mode Links will not work in preview mode

Jun 8, 2023

This week we interview John Milad. John has 25 years of experience as a start-up executive, venture investor, and banker specializing in healthcare innovation across the UK, Europe, and the US. He had 10 years of life sciences venture experience at a family office, Atlas Venture, NBGI Venture and Downing. Notable exits include Symetis, ACT/EPIX, BoneSupport and Medcast/WebMD.

 John is a Co-founder of Quanta Dialysis Technologies, which I led as CEO for 8 years. Notable outcomes include creating an award-winning, disruptive portable dialysis system; raising nearly $400m in funding; commercially launching in UK and US; and establishing trans-Atlantic commercial operations. For another two years, he served as an executive at Nitec Pharma, which was ultimately sold to Horizon Therapeutics.

 John has held multiple board positions across the sector. He has been an advisor to the NIHR i4i programme. Mentor at the Enterprise Hub of the Royal Academy of Engineering.

 He has been recognized in the Sunday Times Maserati List of the UK’s Top 100 “Game Changing Innovators and Entrepreneurs”; Winner of the 2022 MacRobert Award from the Royal Academy of Engineering for outstanding engineering innovation.